Bioorganic and Medicinal Chemistry p. 2261 - 2267 (2019)
Update date:2022-08-11
Topics:
Yin, Yong
Hu, Jia-Qin
Wu, Xu
Sha, Shao
Wang, She-Feng
Qiao, Fang
Song, Zhong-Cheng
Zhu, Hai-Liang
A series of novel chromeno[4,3-c]pyrazol-4(2H)-one derivates contained sulfonamido were designed and synthesized, and their anticancer effects in vitro was evaluated to develop some new PI3Kα inhibitors. Most of desired compounds exhibited the better antiproliferative activities against four cancer cell lines than that of LY294002. Out of them, compound 4o displayed the potent antiproliferative activity and high selectivity against the PI3Kα protein and it can induce apoptosis of HCT116 in a dose-dependent manner. Western blot assay indicated that compound 4o obviously down-regulated expression of p-Akt (S473). Molecular docking was performed to clarify the possible binding mode between compound 4o and PI3Kα. All these results indicated that compound 4o could be a potential inhibitor of PI3Kα.
View MoreContact:86-27-84888681
Address:Wuhan economic & technology development zone
Chengdu Sino-Strong Pharmaceutical Co.,Ltd.
website:http://www.sino-strong.com.cn
Contact:+86-28-82666753
Address:459 West haike road,Cross-straits technological industry park, Wenjiang district,Chengdu, P.R.China
Contact:+86-18653358619
Address:zibo
Anhui Asahikasei Chemical Co., Ltd
Contact:86-551-4259770
Address:No. 88 Linquan Road Hefei Anhui China
HANGZHOU PANYU CHEMICAL CO.,LIMITED
Contact:+86-571-86578491
Address:Rm 605, NO.1870 Binsheng Road,Binjiang Dist, Hangzhou, China
Doi:10.1002/hlca.19470300642
(1947)Doi:10.1021/ja01270a048
(1938)Doi:10.1016/S0040-4039(01)82272-3
(1974)Doi:10.1016/0022-328X(92)80184-Y
(1992)Doi:10.1007/s12039-015-0867-1
(2015)Doi:10.1039/b925377g
(2010)